Edoxaban
| Autor: | Padda IS; CMU School of Medicine, Chowdhury YS; State University of New York - Downstate |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | 2022 Jan. |
| Abstrakt: | Edoxaban is a medication used in the management and treatment of pulmonary embolism (PE), deep venous thrombosis (DVT), and non-valvular atrial fibrillation (NVAF). It is in the direct-acting oral anticoagulant class of drugs. This activity outlines the indications, action, and contraindications for edoxaban as a valuable agent in treating and managing thromboembolic events. This activity will highlight the mechanism of action, adverse event profile, and other key factors pertinent to the healthcare team members in caring for patients with pulmonary embolism, deep venous thrombosis, and non-valvular atrial fibrillation. (Copyright © 2022, StatPearls Publishing LLC.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|